SCYNEXIS Financial Health

Short Term Liabilities: SCYX's short term assets ($103.6M) exceed its short term liabilities ($14.3M).

Long Term Liabilities: SCYX's short term assets ($103.6M) exceed its long term liabilities ($80.8M).

Debt Level: SCYX has more cash than its total debt.

Reducing Debt: SCYX's debt to equity ratio has increased from 53.4% to 261.2% over the past 5 years.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SCYX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: SCYX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 19.4% each year

• Healthy companies in the Pharmaceuticals & Biotech industry.